Treatment and outcomes according to HIV infection status.

VL: visceral leishmaniasis Fever response: the disappearance of fever at the end of treatment Hemoglobin response: patients presenting an increase of 2 g% or more in hemoglobin tax at the end of treatment Leukocyte response: patients presenting an increase of 50% or more in their leukocyte count at the end of treatment Platelet response: patients presenting an increase of 50% or more in their platelet count at the end of treatment Spleen response: a 2 cm or more reduction in spleen size palpation at the end of treatment Clinical cure: no death, recurrence, hepatosplenomegaly or hematological abnormalities IR: 25–75% interquartile range.